The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and differential GLP-1 responses.

The nominee and her brother have criticized processed foods and the pharmaceutical industry, linking poor diets to health issues like obesity, depression and Alzheimer’s. HealthDay News — President ...

Essentially, patients with CRC need significantly more symptom management knowledge to be successful with self-management of symptoms. In addition, social support needs to vary based on the patient’s ...

The approvals of Galdieria extract blue, butterfly pea flower extract, and calcium phosphate were granted to French company Fermentalg, St. Louis-based Sensient Colors, and Innophos of Cranbury, New ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Simultaneous liver transplant and sleeve gastrectomy yield weight loss, diabetes resolution, and reduction in allograft steatosis development.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.